Search

everythinglearnresearchcommunity

for

Search:↓

Henna has potential health benefits and can treat various conditions, but more research is needed to confirm safety and effectiveness.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Inositol shows promise in treating PCOS and other health issues, but more research is needed.

Thyroid hormone may be useful for treating various skin conditions and needs more research.

Finasteride is a safe and effective long-term treatment for male hair loss, especially when started early.

A new microneedle patch made from hair proteins helps regrow hair faster and better than current treatments.

Platelet lysate is a promising, cost-effective option for regenerative medicine with potential clinical applications.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Bee venom might be a good alternative treatment for various skin conditions because it has many healing properties.

Minoxidil effectively treats hair loss, with better results in women.

Topical contact sensitizers can treat certain skin conditions but are rarely used in the U.K.

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.

Skin surface lipids are important for skin health and altering them could help prevent aging and treat skin conditions.

Neuroactive steroids show promise for treating mental and neurological disorders by targeting GABA_A receptors.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Adult skin quickly reacts to short-term environmental and internal stress, leading to various skin issues and the need for protective measures.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

The article suggests that targeting specific immune pathways could help control and treat the skin disease hidradenitis suppurativa.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

Intralesional triamcinolone acetonide effectively treats alopecia areata, as shown by significant improvements in hair regrowth and dermoscopic indicators.

Customized medications made through compounding can be beneficial for various skin conditions but require careful regulation and collaboration between doctors and pharmacists.

Mesenchymal stem cell-derived exosomes significantly increase hair density and thickness in androgenic alopecia patients.

There are significant gaps and inconsistencies in diagnosing and treating alopecia areata in Greece and Italy.

Effective PCOS treatments require targeting specific signaling pathways.

Modified HDL can better deliver drugs and genes, potentially improving treatments and reducing side effects.

The protein CTCF is essential for skin development, maintaining hair follicles, and preventing inflammation.

The 2006 editorial concluded that immunotherapy was advancing with new drugs, focusing on specific biological therapies and convenient oral treatments, and highlighted the importance of partnerships and new regulations in the field.

The secretions of mesenchymal stem cells could be used for healing without using the cells themselves.